MedTrace Logo

Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging

NCT02690818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-04-23

No results posted yet for this study

Summary

The purpose of this pilot study is to determine whether regularly scheduled medication reminder text messages (SMS) are effective in increasing latent tuberculosis infection (LTBI) treatment completion.

Conditions

  • Latent Tuberculosis

Interventions

BEHAVIORAL

Regularly scheduled LTBI medication reminder text messages

Regularly scheduled medication reminder text messages Daily LTBI text messages without the option to text back. The messages will read, "This is a reminder to take your medication."

Sponsors & Collaborators

  • Pima County Health Department

    collaborator UNKNOWN

  • American Lung Association

    collaborator OTHER

  • University of Arizona

    lead OTHER

Principal Investigators

  • Eyal Oren, PhD · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-09-26
Completion
2018-09-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02690818 on ClinicalTrials.gov